Collection of breast cancer tissue and blood samples

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves the collection of tissue samples during standard surgical procedures for patients diagnosed with breast cancer. In addition to tissue, a one-time blood draw will be performed, and there may be an optional rectal swab for biome analysis. The follow-up will consist of chart reviews to monitor for recurrence, metastases, or death. The goal is to gather biospecimens that can be used for future research on breast cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults \>18 years old at time of consent
* Subject must be capable to giving informed consent or have an acceptable surrogate capable of giving consent on the subject behalf.
* Patients with carcinoma in situ or invasive breast cancer
* Patient must be undergoing one of the following:

  * definitive surgical tumor resection for breast cancer OR
  * placement of a vascular access device as a prelude to neoadjuvant therapy for breast cancer OR
  * neurosurgical resection of a brain metastasis from primary breast cancer.

Exclusion Criteria:

* \<18 years old
* Not able to give informed consent and does not have acceptable surrogate capable to giving informed consent.
* Active drug/alcohol dependence or abuse history

Where it's running

• Sidney Kimmel Cancer Center at Thomas Jefferson University
  Philadelphia, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Nicole Simone, MD — Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
• Study coordinator: Nicole Simone, MD
• Email: Nicole.Simone@jefferson.edu
• Phone: 215-955-6702

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 68Ga-FAPI PET/MRI imaging to see if it can track breast cancer response to chemotherapy

  This study tests whether a new imaging scan, 68Ga-FAPI PET/MRI, can show how well invasive breast cancer responds to neoadjuvant chemotherapy in adults.

  Recruiting at 8 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT07899892

• Preoperative partial breast irradiation for early-stage breast cancer

  This study is testing if giving radiation therapy before surgery for early-stage breast cancer can lead to fewer side effects compared to the usual treatment given after surgery.

  Recruiting Phase 2 Yonsei University · Seoul · NCT06677944

• Using tart cherry juice to prevent nerve damage from chemotherapy in breast cancer patients

  This study is testing if drinking tart cherry juice can help prevent nerve damage in breast cancer patients receiving chemotherapy.

  Recruiting Phase 2 University of California, Davis · Sacramento, California · NCT06268665

• Testing a new drug combination for HER2-positive inflammatory breast cancer

  This study is testing a new combination of two drugs to see if they can safely and effectively treat people with stage III HER2-positive inflammatory breast cancer who haven't had treatment before.

  Recruiting at 3 sites Phase 2 Dana-Farber Cancer Institute · Boston, Massachusetts and 2 other locations · NCT05795101

• Alternative treatment for T4 breast cancer involving preoperative radiotherapy and immediate reconstruction

  This study is testing a new treatment for T4 breast cancer that combines radiation before surgery with immediate reconstruction to see if it can improve patient outcomes.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT05412225

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.